| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |